e-therapeutics plc plans to de-list from the London Stock Exchange’s junior AIM market after slamming the risk appetite of UK investors. The MedTech intends to raise £28.9 million by way of a share subscription led by funds managed by existing investors M&G Investment Management and Richard Griffiths. It is also proposing the cancellation of its … Continue reading e-therapeutics plc looks to US, slams risk appetite of UK investors